trandolapril 2 MG Oral Tablet
INDICATIONS AND USAGE Hypertension Trandolapril Tablets are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive medication such as hydrochlorothiazide. Heart Failure Post Myocardial Infarction or Left-Ventricular Dysfunction Post Myocardial Infarction Trandolapril Tablets are indicated in stable patients who have evidence of left-ventricular systolic dysfunction (identified by wall motion abnormalities) or who are symptomatic from congestive heart failure within the first few days after sustaining acute myocardial infarction. Administration of trandolapril to Caucasian patients has been shown to decrease the risk of death (principally cardiovascular death) and to decrease the risk of heart failure-related hospitalization (see CLINICAL PHARMACOLOGY -Heart Failure or Left-Ventricular Dysfunction Post Myocardial Infarction for details of the survival trial).
Teva Pharmaceuticals USA Inc
OVAL YELLOW 93 7326
93 7326 OVAL YELLOW
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED/STORAGE AND HANDLING Trandolapril Tablets are supplied as follows: 1 mg: mottled salmon, capsule-shaped tablet, scored on one side and debossed with “9” on one side of the score and with “3” on the other side. debossed with “7325” on the other side of the tablet. Available in bottles of 100 tablets (NDC 0093-7325-01). 2 mg: mottled yellow, capsule-shaped tablet, debossed with “93” on one side and with “7326” on the other side of the tablet. Available in bottles of 100 tablets (NDC 0093-7326-01). 4 mg: mottled rose, capsule-shaped tablet, debossed with “93” on one side and with “7327” on the other side of the tablet. Available in bottles of 100 tablets (NDC 0093-7327-01). Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 9777402, Israel Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Rev. J 6/2015
More pills like OVAL 93 7326